CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.

CD40, a member of tumor necrosis factor receptor superfamily, and its cognate ligand CD40L are both elevated in the brain of Alzheimer's disease (AD) patients compared to controls. We have shown that pharmacological or genetic interruption of CD40/CD40L interaction results in mitigation of AD-like pathology in vivo in transgenic AD mouse models, and in vitro. Recently, we showed that CD40L stimulation could increase Abeta levels via NFkappaB signaling, presumably through TRAFs. In the present work, using CD40 mutants, we show that CD40L can increase levels of Abeta(1-40), Abeta(1-42), sAPPbeta, sAPPalpha and CTFbeta independently of TRAF signaling. We report an increase in mature/immature APP ratio after CD40L treatment of CD40wt and CD40-mutant cells, reflecting alterations in APP trafficking. In addition, results from CD40L treatment of a neuroblastoma cell line over-expressing the C-99 APP fragment suggest that CD40L has an effect on gamma-secretase. Furthermore, inhibition of gamma-secretase activity significantly reduces sAPPbeta levels in the CD40L treated HEK/APPsw CD40wt and the CD40-mutant cells. The latter suggests CD40/CD40L interaction primarily acts on gamma-secretase and affects beta-secretase via a positive feedback mechanism. Taken together, our data suggest that CD40/CD40L interaction modulates APP processing independently of TRAF signaling.

[1]  P. Moynagh,et al.  Tumour-necrosis-factor-receptor-associated factor 6, NF-kappaB-inducing kinase and IkappaB kinases mediate IgE isotype switching in response to CD40. , 2000, The Biochemical journal.

[2]  C. Volmar,et al.  CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models , 2006, Journal of Neuroinflammation.

[3]  M. Kehry,et al.  CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. , 1996, Journal of immunology.

[4]  Daniel Paris,et al.  Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease. , 2008, Cytokine.

[5]  D. Goeddel,et al.  TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.

[6]  R. Tanzi,et al.  hFE65L Influences Amyloid Precursor Protein Maturation and Secretion , 1999, Journal of neurochemistry.

[7]  J. Inoue,et al.  TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Mattson,et al.  Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer's disease , 2010, Neurobiology of Aging.

[9]  M. Mattson,et al.  Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein , 2007 .

[10]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[11]  M. Boguski,et al.  A novel RING finger protein interacts with the cytoplasmic domain of CD40. , 1994, The Journal of biological chemistry.

[12]  D. Baltimore,et al.  Involvement of CRAF1, a relative of TRAF, in CD40 signaling , 1995, Science.

[13]  C. Volmar,et al.  CD40 promotion of amyloid beta production occurs via the NF‐κB pathway , 2007 .

[14]  Masanori Kato,et al.  Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases , 2000, Brain Research.

[15]  B. Hyman,et al.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Mullan,et al.  CD40 signaling and Alzheimer's disease pathogenesis , 2001, Neurochemistry International.

[17]  D. Baltimore,et al.  TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. , 1996, Genes & development.

[18]  John Calvin Reed,et al.  A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40 , 1995, FEBS letters.

[19]  R. Flavell,et al.  Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice , 2002, Nature Neuroscience.

[20]  L. Young,et al.  Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors , 1997, Oncogene.

[21]  D. Selkoe,et al.  The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Protein a , 1996 .

[22]  B. Aggarwal,et al.  Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. , 1999, The Journal of biological chemistry.

[23]  W. Ling,et al.  Lipid rafts regulate cellular CD40 receptor localization in vascular endothelial cells. , 2007, Biochemical and biophysical research communications.

[24]  P. Ramakrishnan,et al.  TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Y. Wu,et al.  Induction of CD40 on human endothelial cells by Alzheimer’s β-amyloid peptides , 1999, Brain Research Bulletin.

[26]  R. Noelle,et al.  Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent , 2002, European journal of immunology.

[27]  V. Mathura,et al.  Genomic regulation after CD40 stimulation in microglia: relevance to Alzheimer's disease. , 2005, Brain research. Molecular brain research.

[28]  M. Kehry,et al.  CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs) , 1999, The Journal of Biological Chemistry.

[29]  C. Volmar,et al.  Behavioral effects of CD40–CD40L pathway disruption in aged PSAPP mice , 2004, Brain Research.

[30]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.

[31]  Xuejun Jiang,et al.  Internalization of CD40 regulates its signal transduction in vascular endothelial cells. , 2006, Biochemical and biophysical research communications.

[32]  John Calvin Reed,et al.  CD40‐mediated activation of Ig‐Cγ1‐ and Ig‐Cϵ germ‐line promoters involves multiple TRAF family proteins , 1999 .

[33]  I. Berberich,et al.  The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti‐IgM‐induced growth arrest , 1998, European journal of immunology.

[34]  C. Volmar,et al.  CD40 ligation mediates plaque-associated tau phosphorylation in β-amyloid overproducing mice , 2008, Brain Research.

[35]  M. Kehry,et al.  CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. , 1998, Biochemistry.

[36]  M. Mullan,et al.  CD40-CD40L interaction in Alzheimer's disease. , 2002, Current opinion in pharmacology.

[37]  A. Placzek,et al.  Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40 , 1998, Brain Research.

[38]  G. Wang,et al.  Cholesterol-Dependent and -Independent CD40 Internalization and Signaling Activation in Cardiovascular Endothelial Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[39]  M. Mattson,et al.  Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. , 1999, Science.

[40]  E. Kieff,et al.  Identification of TRAF6, a Novel Tumor Necrosis Factor Receptor-associated Factor Protein That Mediates Signaling from an Amino-terminal Domain of the CD40 Cytoplasmic Region* , 1996, The Journal of Biological Chemistry.

[41]  Phillip B. Jones,et al.  Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Aβ Secretion* , 2006, Journal of Biological Chemistry.